Related Experiment Video
Updated: Feb 13, 2026

A Caenorhabditis elegans Nutritional-status Based Copper Aversion Assay
Published on: July 26, 2017
Copper Supplementation in Premature Infants With Parenteral Nutrition-Associated Cholestasis
Kunal Gupta1, Hongyue Wang2, Sanjiv B Amin3
1Division of Neonatology, Department of Pediatrics, Hennepin County Medical Center, Minneapolis, Minnesota, USA.
Insights
Intermittent parenteral copper supplementation (IPC) did not affect serum copper levels or indicators of toxicity/deficiency in premature infants with parenteral nutrition-associated cholestasis (PNAC). Copper status is primarily influenced by prematurity and postmenstrual age.
Area of Science:
- Neonatology
- Nutritional Science
- Pediatric Gastroenterology
Background:
- Parenteral nutrition-associated cholestasis (PNAC) is a complication in premature infants.
- Copper is essential but can be toxic; its role in PNAC requires clarification.
- Intermittent parenteral copper supplementation (IPC) is used, but its impact on copper status in PNAC is unknown.
Purpose of the Study:
- To assess the effect of IPC on serum copper status in premature infants with PNAC.
- To evaluate IPC's association with biochemical and hematological markers of copper toxicity and deficiency.
- To identify factors influencing copper status in this vulnerable population.
Main Methods:
- Prospective observational study of 24 premature infants with PNAC receiving IPC.
- Exclusion of infants with specific genetic, infectious, or surgical conditions.
- Regular monitoring of serum copper, liver enzymes, and hematological parameters.
Main Results:
- IPC showed no significant association with serum copper concentration after controlling for gestational age (GA) and baseline intake.
- IPC was not linked to markers of hepatotoxicity (ALT, AST) or copper deficiency (platelets, Hct, WBC, neutrophils).
- GA and postmenstrual age were independently associated with serum copper levels.
Conclusions:
- IPC does not appear to alter copper status in premature infants with PNAC.
- Copper status in these infants is primarily determined by prematurity and postmenstrual age.
- Further research may be needed to optimize copper management in PNAC.
Abstract:
The aim of this study was to evaluate the effect of intermittent parenteral copper supplementation (IPC) on serum copper status and biochemical and hematological measures of copper toxicity and deficiency in premature infants with parenteral nutrition (PN)-associated cholestasis (PNAC). We performed a prospective nested observational study in premature infants with PNAC who received IPC after the development of PNAC. Infants with chromosomal disorders, TORCH (toxoplasmosis, parvovirus, syphilis, rubella, cytomegalovirus, herpes, human immunodeficiency virus) infection, metabolic disorder, and/or surgical abnormality of the hepatobiliary system were excluded. Serum copper concentrations were measured once every 2-4 weeks while receiving PN; 24 premature infants were studied. The mean gestational age (GA) of infants was 28.6 ± 4.7 weeks. On regression analysis, there was no significant association between IPC and serum copper concentration (coefficient 2.72, 95% CI: -27 to 32; P = .84) after controlling for GA, gender, and baseline copper intake before PNAC. There was no significant association of IPC with alanine and aspartate transaminases levels (hepatotoxicity) and platelet count, hematocrit, white blood cell count, and neutrophil count (measures of copper deficiency) after controlling for confounders. GA and postmenstrual age were independently and positively associated with serum copper concentration after controlling for confounders on regression analyses. Thus, IPC in premature infants with PNAC does not influence copper status and is not associated with biochemical and hematological measures of copper deficiency and/or toxicity. Serum copper concentration in premature infants with PNAC receiving IPC is determined by the degree of prematurity and postmenstrual age.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
The Roles of Bacteria and Fungi in Plant Nutrition
Parenteral Anesthetics: Overview
Key Elements for Plant Nutrition
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...